Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,928.00    36.00 (1.90%)
Bid:
1,912.00
Ask:
1,914.00
Spread: 2.00 (0.105%)
Market Cap: £3.24b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Johnson Matthey Battery Materials update

12 Jan 2022 14:19

RNS Number : 2549Y
Johnson Matthey PLC
12 January 2022
 

12th January 2022

 

Johnson Matthey Plc

(the Company)

Johnson Matthey provides an update on its intention to exit Battery Materials

 

Johnson Matthey, a global leader in sustainable technologies, today provides an update on its intention to exit Battery Materials.

 

On 11th November 2021, we announced our intention to pursue the sale of all or parts of our Battery Materials business with the ultimate intention of exiting. Further to that announcement, we have held discussions with a number of parties about a sale of the entire business. These discussions have not resulted in an agreement to sell the entire business as a going concern. Consequently, we are announcing today that we are commencing consultation with our employees about our proposed closure of the Battery Materials business, and we are pursuing the sale of its individual assets.

 

In our interim results we fully impaired the carrying value of our battery materials assets as at 30th September 2021, resulting in a charge of £314 million. While the outcome of the sales process is uncertain, full or partial closure will result in additional impairment charges, the settlement of contractual liabilities, redundancy, closure and abandonment costs as we indicated at our interim results on 24th November 2021. After anticipated asset disposal proceeds, we currently estimate these cash costs will be in the order of £150 million, which will be recorded as an exceptional item outside of underlying operating profit in our full year results.

 

 

ENDS

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

Media

Barney Wyld

Harry Cameron

 

 

Group Corporate Affairs Director

Tulchan Communications

 

 

+44 7485 337498

+44 20 7353 4200

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEALFAFFXAEFA
Date   Source Headline
13th Nov 20204:45 pmRNSHolding(s) in Company
22nd Oct 20204:49 pmRNSDirector/PDMR Shareholding
29th Sep 20204:52 pmRNSDirector/PDMR Shareholding
21st Sep 20204:08 pmRNSDirector/PDMR Shareholding
18th Sep 20204:21 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSJohnson Matthey: Hydrogen Seminar
21st Aug 20209:05 amRNSDirector/PDMR Shareholding
11th Aug 202010:12 amRNSDoug Webb - New Directorship
6th Aug 20204:19 pmRNSDirector/PDMR Shareholding
6th Aug 20204:11 pmRNSDirector/PDMR Shareholding
5th Aug 20204:25 pmRNSDirector/PDMR Shareholding
5th Aug 20204:21 pmRNSDirector/PDMR Shareholding
5th Aug 20204:04 pmRNSDirector/PDMR Shareholding
30th Jul 20202:45 pmRNSDirector Declaration
23rd Jul 20203:25 pmRNSResult of AGM
23rd Jul 20207:00 amRNSJohnson Matthey Q1 AGM trading update
17th Jul 20201:31 pmRNSDirector/PDMR Shareholding
14th Jul 202012:18 pmRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSAnna Manz, CFO, to leave JM and join LSEG
23rd Jun 20207:00 amRNSAnnual Financial Report
19th Jun 20203:14 pmRNSDirector/PDMR Shareholding
16th Jun 20205:13 pmRNSDirector/PDMR Shareholding
16th Jun 20209:00 amRNSCompany Secretary Change
11th Jun 20207:00 amRNSPreliminary results for year ended 31st March 2020
4th Jun 20204:35 pmRNSDirector/PDMR Shareholding
21st May 20204:08 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSJohnson Matthey revised date for full year results
28th Apr 20203:45 pmRNSRights attaching to ordinary shares
22nd Apr 20207:00 amRNSJM and COVID-19: supporting our stakeholders
16th Apr 20204:56 pmRNSDirector/PDMR Shareholding
2nd Apr 202010:31 amRNSJane Griffiths - New Directorship
1st Apr 20207:00 amRNSCompany Secretary Change
30th Mar 20207:00 amRNSJohnson Matthey pre-close trading statement
19th Mar 20203:11 pmRNSDirector/PDMR Shareholding
25th Feb 202011:04 amRNSDirector/PDMR Shareholding
20th Feb 20203:35 pmRNSDirector/PDMR Shareholding
6th Feb 20205:33 pmRNSDirector/PDMR Shareholding
6th Feb 20203:52 pmRNSDirector/PDMR Shareholding
6th Feb 20203:41 pmRNSDirector/PDMR Shareholding
6th Feb 20203:29 pmRNSDirector/PDMR Shareholding
4th Feb 20207:30 amRNSJohn O'Higgins - New Directorship
17th Jan 202010:09 amRNSDirector/PDMR Shareholding
19th Dec 20194:31 pmRNSDirector/PDMR Shareholding
26th Nov 20195:06 pmRNSHolding(s) in Company
26th Nov 20195:01 pmRNSDirector/PDMR Shareholding
26th Nov 20194:53 pmRNSDirector/PDMR Shareholding
26th Nov 20194:41 pmRNSDirector/PDMR Shareholding
25th Nov 201911:56 amRNSDirector/PDMR Shareholding
25th Nov 201910:18 amRNSDirector/PDMR Shareholding
21st Nov 20192:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.